
Reset all filters
01 4Onglyza/Kombiglyze XR/Komboglyze
02 1Onglyza/Kombiglyze Xr/Komboglyze
Saxagliptin, Metoprolol Hydrochloride
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 820
2014 Revenue in Millions : 786
Growth (%) : -4%
Saxagliptin, Metoprolol Hydrochloride
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 611
2016 Revenue in Millions : 720
Growth (%) : -15
Saxagliptin, Metoprolol Hydrochloride
Main Therapeutic Indication : Diabetes
Currency : USD
2014 Revenue in Millions : 116.90%
2013 Revenue in Millions :
Growth (%) :
Saxagliptin, Metoprolol Hydrochloride
Main Therapeutic Indication : Diabetes
Currency : USD
2018 Revenue in Millions : 543
2017 Revenue in Millions : 611
Growth (%) : -11%
Saxagliptin, Metoprolol Hydrochloride
Main Therapeutic Indication : Diabetes
Currency : USD
2016 Revenue in Millions : 720
2015 Revenue in Millions : 786
Growth (%) : -8